Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.

Georgianos, Panagiotis I; Sarafidis, Pantelis A; Liakopoulos, Vassilios; Balaskas, Elias V; Zebekakis, Pantelis E

Georgianos, Panagiotis I; Sarafidis, Pantelis A; Liakopoulos, Vassilios; Balaskas, Elias V; Zebekakis, Pantelis E.

Afiliação

Georgianos PI; Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Sarafidis PA; Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Liakopoulos V; Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Balaskas EV; Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Zebekakis PE; Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

J Clin Hypertens (Greenwich) ; 18(3): 197-9, 2016 Mar.

Article em En | MEDLINE | ID: mdl-26456776

Assuntos

Falência Renal Crônica; Receptores de Mineralocorticoides; Aldosterona; Humanos; Hipertensão/tratamento farmacológico; Antagonistas de Receptores de Mineralocorticoides/uso terapêutico; Espironolactona/uso terapêutico

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Mineralocorticoides / Falência Renal Crônica Limite: Humans Idioma: En Revista: J Clin Hypertens (Greenwich) Assunto da revista: ANGIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Grécia País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google